Live Breaking News & Updates on Agio brand solutions

Stay informed with the latest breaking news from Agio brand solutions on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Agio brand solutions and stay connected to the pulse of your community

Agios Pharmaceuticals (NASDAQ:AGIO) Shares Up 9%

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report)’s stock price was up 9% during mid-day trading on Thursday . The company traded as high as $29.22 and last traded at $29.22. Approximately 362,598 shares changed hands during trading, a decline of 57% from the average daily volume of 840,643 shares. The stock had previously closed […]

Canada , Hong-kong , China , James-william-burns , Brian-goff , Nasdaq , Tower-research-capital , Quest-partners , Agios-pharmaceuticals , Insider-transactions-at-agios-pharmaceuticals , Royal-bank , News-ratings-for-agios-pharmaceuticals-daily

Agios Pharmaceuticals (NASDAQ:AGIO) Price Target Lowered to $42.00 at Royal Bank of Canada

Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its price objective lowered by Royal Bank of Canada from $43.00 to $42.00 in a research note released on Friday morning, Benzinga reports. The brokerage currently has an outperform rating on the biopharmaceutical company’s stock. AGIO has been the subject of a number of other reports. The Goldman […]

Canada , Tsveta-milanova , Jacqualyna-fouse , Securities-exchange-commission , Vanguard-group-inc , Goldman-sachs-group , Metlife-investment-management , Agios-pharmaceuticals-trading-down , Envestnet-asset-management-inc , Dimensional-fund-advisors , Cantor-fitzgerald , News-ratings-for-agios-pharmaceuticals-daily

Agios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Down After Earnings Miss

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) gapped down prior to trading on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $25.90, but opened at $24.93. Agios Pharmaceuticals shares last traded at $25.44, with a volume of 66,412 shares. The biopharmaceutical company reported ($1.72) earnings per […]

Canada , Brian-goff , Cecilia-jones , Jpmorgan-chase-co , Dimensional-fund-advisors , News-ratings-for-agios-pharmaceuticals-daily , Goldman-sachs-group , Agios-pharmaceuticals-inc , Royal-bank , Cantor-fitzgerald , Norges-bank , Nasdaq

Agios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Down After Earnings Miss

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) gapped down prior to trading on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $25.90, but opened at $24.93. Agios Pharmaceuticals shares last traded at $25.44, with a volume of 66,412 shares. The biopharmaceutical company reported ($1.72) earnings per […]

Canada , Brian-goff , Cecilia-jones , Cantor-fitzgerald , Jpmorgan-chase-co , Dimensional-fund-advisors , News-ratings-for-agios-pharmaceuticals-daily , Goldman-sachs-group , Royal-bank , Agios-pharmaceuticals-inc , Securities-exchange-commission , Agios-pharmaceuticals

Headlands Technologies LLC Raises Stock Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)

Headlands Technologies LLC raised its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 31.3% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,037 shares of the biopharmaceutical company’s stock after acquiring an additional 2,153 shares during the quarter. Headlands Technologies LLC’s holdings […]

China , Hong-kong , James-william-burns , Brian-goff , Goldman-sachs-group , Agios-pharmaceuticals-stock-performance , Quarter-for-agios-pharmaceuticals , Agios-pharmaceuticals-inc , Tower-research-capital , Headlands-technologies , China-universal-asset-management-co , Hong-kong-ltd

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) to Post Q3 2024 Earnings of ($1.48) Per Share, Leerink Partnrs Forecasts

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Leerink Partnrs issued their Q3 2024 earnings per share (EPS) estimates for shares of Agios Pharmaceuticals in a research report issued to clients and investors on Monday, February 5th. Leerink Partnrs analyst A. Berens expects that the biopharmaceutical company will post earnings per share of […]

Cecilia-jones , James-william-burns , Leerink-partnrs , Agios-pharmaceuticals-inc , Agios-pharmaceuticals , News-ratings-for-agios-pharmaceuticals-daily , Nasdaq , Metlife-investment-management , Envestnet-asset-management-inc , Dimensional-fund-advisors , Securities-exchange-commission , Vanguard-group-inc

New standards in sustainable refrigerated circulators in all performance classes

With the introduction of several new refrigerated circulators, Julabo now offers environmentally friendly and energy-efficient units across the entire performance range from 200 watts to 2. Click to read more...

Corio , Efrigerated , Irculators , Yneo , Agio , Ooling , Ffers , Apacity , Ulabo , Nergy ,

FY2024 EPS Estimates for Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Lifted by Analyst

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Zacks Research raised their FY2024 EPS estimates for Agios Pharmaceuticals in a note issued to investors on Thursday, January 25th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will post earnings of ($6.05) per share for the year, up from their previous […]

China , Hong-kong , Brian-goff , Jacqualyna-fouse , Lazard-asset-management , Agios-pharmaceuticals-trading-down , Agios-pharmaceuticals-company-profile , Agios-pharmaceuticals-inc , Tower-research-capital , Nasdaq , Analysts-at-zacks-research , Zacks-research

Agios Pharmaceuticals (NASDAQ:AGIO) Shares Up 5.2%

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) were up 5.2% on Thursday . The company traded as high as $23.24 and last traded at $22.62. Approximately 365,022 shares changed hands during mid-day trading, a decline of 62% from the average daily volume of 962,941 shares. The stock had previously closed at $21.51. […]

Hong-kong , China , Jacqualyna-fouse , Brian-goff , Hong-kong-ltd , China-universal-asset-management-co , Nasdaq , Agios-pharmaceuticals-inc , Lazard-asset-management , News-ratings-for-agios-pharmaceuticals-daily , Goldman-sachs-group , Ameritas-investment-partners-inc

Insider Selling: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Director Sells $232,024.08 in Stock

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) Director Jacqualyn A. Fouse sold 10,722 shares of the business’s stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $21.64, for a total transaction of $232,024.08. Following the transaction, the director now owns 129,253 shares in the company, valued […]

China , Hong-kong , Jacqualyna-fouse , Quarter-for-agios-pharmaceuticals , Goldman-sachs-group , Tower-research-capital , Agios-pharmaceuticals-stock-down , Securities-exchange-commission , Hong-kong-ltd , Nasdaq , Ameritas-investment-partners-inc